SSY Fundamental Analysis - SUNLINK HEALTH SYSTEMS INC

Fundamental Rating

We assign a fundamental rating of 4 out of 10 to SSY. SSY was compared to 101 industry peers in the Health Care Providers & Services industry. No worries on liquidiy or solvency for SSY as it has an excellent financial health rating, but there are worries on the profitability. SSY has a expensive valuation and it also scores bad on growth.

Quickly go to:

1. Profitability

1.1 Basic Checks

SSY had positive earnings in the past year.

SSY had a negative operating cash flow in the past year.

SSY had negative earnings in 4 of the past 5 years.

In multiple years SSY reported negative operating cash flow during the last 5 years.

1.2 Ratios

SSY has a Return On Assets of 9.87%. This is amongst the best in the industry. SSY outperforms 93.27% of its industry peers.

Looking at the Return On Equity, with a value of 12.86%, SSY belongs to the top of the industry, outperforming 80.77% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	9.87%
ROE	12.86%
ROIC	N/A

ROA(3y)N/A

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

Looking at the Profit Margin, with a value of 5.55%, SSY is in the better half of the industry, outperforming 79.81% of the companies in the same industry.

SSY has a Gross Margin of 43.05%. This is in the better half of the industry: SSY outperforms 70.19% of its industry peers.

SSY's Gross Margin has declined in the last couple of years.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	5.55%
GM	43.05%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-10.82%

GM growth 5Y-5.67%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

SSY does not have a ROIC to compare to the WACC, probably because it is not profitable.

SSY has more shares outstanding than it did 1 year ago.

The number of shares outstanding for SSY has been increased compared to 5 years ago.

There is no outstanding debt for SSY. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

SSY has an Altman-Z score of 2.88. This is not the best score and indicates that SSY is in the grey zone with still only limited risk for bankruptcy at the moment.

SSY's Altman-Z score of 2.88 is fine compared to the rest of the industry. SSY outperforms 61.54% of its industry peers.

SSY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	2.88

ROIC/WACCN/A

WACC8.9%

2.3 Liquidity

SSY has a Current Ratio of 3.91. This indicates that SSY is financially healthy and has no problem in meeting its short term obligations.

With an excellent Current ratio value of 3.91, SSY belongs to the best of the industry, outperforming 88.46% of the companies in the same industry.

A Quick Ratio of 3.50 indicates that SSY has no problem at all paying its short term obligations.

SSY has a Quick ratio of 3.50. This is amongst the best in the industry. SSY outperforms 88.46% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	3.91
Quick Ratio	3.5

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 125.41% over the past year.

The Revenue for SSY has decreased by -12.45% in the past year. This is quite bad

SSY shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -6.58% yearly.

EPS 1Y (TTM)125.41%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%52.89%

Revenue 1Y (TTM)-12.45%

Revenue growth 3Y-7.28%

Revenue growth 5Y-6.58%

Sales Q2Q%-1.86%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 4.29 indicates a rather cheap valuation of SSY.

99.04% of the companies in the same industry are more expensive than SSY, based on the Price/Earnings ratio.

When comparing the Price/Earnings ratio of SSY to the average of the S&P500 Index (26.51), we can say SSY is valued rather cheaply.

		Industry Rank	Sector Rank
PE	4.29
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

SSY does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

SUNLINK HEALTH SYSTEMS INC

NYSEARCA:SSY (8/14/2025, 8:04:00 PM)

After market: 1.0701 -0.04 (-4.03%)

1.115

+0.16 (+16.15%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Providers & Services

Earnings (Last)05-14 2025-05-14

Earnings (Next)09-29 2025-09-29

Inst Owners11.33%

Inst Owner Change-100%

Ins Owners28.31%

Ins Owner Change-145.48%

Market Cap7.85M

Revenue(TTM)31.09M

Net Income(TTM)1.73M

Analysts0

Price TargetN/A

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	4.29
Fwd PE	N/A
P/S	0.25
P/FCF	N/A
P/OCF	N/A
P/B	0.59
P/tB	0.64
EV/EBITDA	N/A

EPS(TTM)0.26

EY23.32%

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)-0.55

FCFYN/A

OCF(TTM)-0.42

OCFYN/A

SpS4.42

BVpS1.9

TBVpS1.74

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	9.87%
ROE	12.86%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	5.55%
GM	43.05%
FCFM	N/A

ROA(3y)N/A

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-10.82%

GM growth 5Y-5.67%

F-Score4

Asset Turnover1.78

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	48.16%
Cap/Sales	3.03%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	3.91
Quick Ratio	3.5
Altman-Z	2.88

F-Score4

WACC8.9%

ROIC/WACCN/A

Cap/Depr(3y)133.35%

Cap/Depr(5y)134.66%

Cap/Sales(3y)5.57%

Cap/Sales(5y)5.12%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)125.41%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%52.89%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-12.45%

Revenue growth 3Y-7.28%

Revenue growth 5Y-6.58%

Sales Q2Q%-1.86%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y3.96%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-78.86%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-451.48%

OCF growth 3YN/A

OCF growth 5YN/A

SUNLINK HEALTH SYSTEMS INC / SSY FAQ

What is the ChartMill fundamental rating of SUNLINK HEALTH SYSTEMS INC (SSY) stock?

ChartMill assigns a fundamental rating of 4 / 10 to SSY.

Can you provide the valuation status for SUNLINK HEALTH SYSTEMS INC?

ChartMill assigns a valuation rating of 2 / 10 to SUNLINK HEALTH SYSTEMS INC (SSY). This can be considered as Overvalued.

What is the profitability of SSY stock?

SUNLINK HEALTH SYSTEMS INC (SSY) has a profitability rating of 3 / 10.

Can you provide the financial health for SSY stock?

The financial health rating of SUNLINK HEALTH SYSTEMS INC (SSY) is 8 / 10.

SUNLINK HEALTH SYSTEMS INC (SSY) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

SUNLINK HEALTH SYSTEMS INC / SSY FAQ

What is the ChartMill fundamental rating of SUNLINK HEALTH SYSTEMS INC (SSY) stock?

Can you provide the valuation status for SUNLINK HEALTH SYSTEMS INC?

What is the profitability of SSY stock?

Can you provide the financial health for SSY stock?